ICON Q4 2025 Earnings EPS Miss Highlights Operational Challenges PRME Q1 2026 Earnings EPS Worse Than Expected as PreRevenue Biotech Advances Pipeline PSKY Q1 2026 Earnings EPS Surges Past Estimates with 5182 Beat ThredUp TDUP Q1 2026 Earnings Narrow Loss Beats Estimates but Stock Slips on Revenue Concerns ESLT Q4 2025 Earnings Strong EPS Beat Amid Defense Sector Demand CRVS Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Continues Pipeline Progress